Literature DB >> 22983900

In vitro antifungal activity of micafungin and caspofungin against dermatophytes isolated from China.

Ying-qiu Bao1, Zhe Wan, Ruo-yu Li.   

Abstract

AIMS: The aims of this study are to investigate the in vitro activities of micafungin and caspofungin that are two new echinocandin antifungal drugs against clinically isolated dermatophytes in China and to define MEC (minimal effective concentration) as the reading endpoints of this study in accordance with (Clinical and laboratory Standards Institute) CLSI M38-A2 reference.
METHODS: Minimal effective concentrations (MECs) of micafungin and caspofungin for 82 dermatophyte strains were determined according to CLSI (formerly NCCLS) M38-A2 broth microdilution methods.
RESULTS: (1) The MEC(90s) of micafungin for Trichophyton violaceum and Trichophyton tonsurans were 0.25 μg/mL, and for Microsporum canis and Trichophyton verrucosum were 0.06 μg/mL. The MEC(90s) for Trichophyton rubrum, Trichophyton mentagrophytes, Microsporum gypseum and Epidermophyton floccosum were 0.03 μg/mL. (2) The MEC(90s) of caspofungin for T. rubrum, T. violaceum and T. tonsurans were 1 μg/mL, and for T. mentagrophytes, M. canis, M. gypseum, E. floccosum and T. verrucosum were 0.5 μg/mL. (3) Compared with caspofungin, micafungin demonstrated lower MEC value to dermatophytes (P < 0.05).
CONCLUSIONS: Micafungin has stronger in vitro antifungal activity than caspofungin.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22983900     DOI: 10.1007/s11046-012-9571-6

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  9 in total

Review 1.  Fungal beta(1,3)-D-glucan synthesis.

Authors:  C M Douglas
Journal:  Med Mycol       Date:  2001       Impact factor: 4.076

2.  In vitro activity of FK463, a novel lipopeptide antifungal agent, against a variety of clinically important molds.

Authors:  T Nakai; J Uno; K Otomo; F Ikeda; S Tawara; T Goto; K Nishimura; M Miyaji
Journal:  Chemotherapy       Date:  2002-05       Impact factor: 2.544

3.  Antifungal susceptibilities of dermatophytic agents isolated from clinical specimens.

Authors:  Zafer Cetinkaya; Nuri Kiraz; Semsettin Karaca; Mustafa Kulac; Ihsan H Ciftci; Orhan C Aktepe; Mustafa Altindis; Nilay Kiyildi; Meltem Piyade
Journal:  Eur J Dermatol       Date:  2005 Jul-Aug       Impact factor: 3.328

4.  Efficacy of FK463, a (1,3)-beta-D-glucan synthase inhibitor, in disseminated azole-resistant candida albicans infection in mice.

Authors:  S Maesaki; M A Hossain; Y Miyazaki; K Tomono; T Tashiro; S Kohno
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

Review 5.  Pharmacokinetics/pharmacodynamics of echinocandins.

Authors:  U Theuretzbacher
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-10-14       Impact factor: 3.267

6.  New methods to assess susceptibilities of Aspergillus isolates to caspofungin.

Authors:  Alexander Imhof; S Arunmozhi Balajee; Kieren A Marr
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

7.  Comparison of two methods and three end points in determination of in vitro activity of micafungin against Aspergillus spp.

Authors:  Sevtap Arikan; Pinar Yurdakul; Gulsen Hascelik
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

8.  Deep infection by Trichophyton rubrum in an immunocompromised patient.

Authors:  Ran Nir-Paz; Hila Elinav; Gerald E Pierard; David Walker; Alexander Maly; Mervyn Shapiro; Richard C Barton; Itzhack Polacheck
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

9.  Pseudomycetoma caused by Microsporum canis in an immunosuppressed patient: a case report and review of the literature.

Authors:  Jena C Berg; Kirsten L Hamacher; Glenn D Roberts
Journal:  J Cutan Pathol       Date:  2007-05       Impact factor: 1.587

  9 in total
  5 in total

1.  In vitro antifungal activity of heterocyclic organoboron compounds against Trichophyton mentagrophytes and Microsporum canis obtained from clinical isolates.

Authors:  Meryem Pir; Fatma Budak; Kemal Metiner
Journal:  Braz J Microbiol       Date:  2022-06-13       Impact factor: 2.214

Review 2.  Newer Topical Treatments in Skin and Nail Dermatophyte Infections.

Authors:  Kanika Sahni; Sanjay Singh; Sunil Dogra
Journal:  Indian Dermatol Online J       Date:  2018 May-Jun

3.  Synergism between the Antidepressant Sertraline and Caspofungin as an Approach to Minimise the Virulence and Resistance in the Dermatophyte Trichophyton rubrum.

Authors:  Carlos H Lopes Rocha; Flaviane M Galvão Rocha; Tamires A Bitencourt; Maíra P Martins; Pablo R Sanches; Antonio Rossi; Nilce M Martinez-Rossi
Journal:  J Fungi (Basel)       Date:  2022-08-03

4.  Molecular Identification and Antifungal Susceptibility Patterns of Dermatophytes Isolated from Companion Animals with Clinical Symptoms of Dermatophytosis.

Authors:  Farzad Katiraee; Yasaman Kouchak Kosari; Minoo Soltani; Hojjatollah Shokri; Mohammad Hassan Minooieanhaghighi
Journal:  J Vet Res       Date:  2021-04-23       Impact factor: 1.744

Review 5.  Dermatophyte Resistance to Antifungal Drugs: Mechanisms and Prospectus.

Authors:  Nilce M Martinez-Rossi; Tamires A Bitencourt; Nalu T A Peres; Elza A S Lang; Eriston V Gomes; Natalia R Quaresemin; Maíra P Martins; Lucia Lopes; Antonio Rossi
Journal:  Front Microbiol       Date:  2018-05-29       Impact factor: 5.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.